The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF). 

 -  2021 
<br/><br/><br/>English 
<br/><br/><label>ISSN: </label>1388-9842 
<br/><br/><label>Standard No.: </label>10.1002/ejhf.2181 [doi] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>*Heart Failure<br/>*Heart Failure, Systolic<br/>Cardiac Myosins<br/>Heart Failure, Systolic/dt [Drug Therapy]<br/>Heart Failure/dt [Drug Therapy]<br/>Humans<br/>Stroke Volume<br/>Urea/aa [Analogs & Derivatives]
<br/><br/><label>Subjects--Geographic Terms: </label><br/>MedStar Heart & Vascular Institute
<br/><br/><label>Index Terms--Function: </label><br/>Letter